Reports
RECENT NEWS
Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent
Waiving patent protection discourages cutting-edge research investments, which in turn produce breakthrough treatments no... Read more
'I'm hopeful for the future': Alzheimer's drug approved by FDA
Peter Pitts of CMPI and Dr. Ronald Petersen of the Mayo Clinic discuss the FDA's approval of aducanumab... Read more
Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice
Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta... Read more